Navigation Links
Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
Date:8/9/2012

SAN DIEGO, Aug. 9, 2012 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today reported financial results for the second quarter ended June 30, 2012, and reviewed recent developments.

At June 30, 2012, cash and cash equivalents totaled $143.8 million, which does not include (i) the $20.0 million milestone payment received from Eisai Inc. subsequent to June 30 for the inclusion of the efficacy and safety data from the Phase 3 BLOOM-DM (Behavioral modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus) clinical trial in patients with type 2 diabetes in the US Food and Drug Administration (FDA)-approved prescribing information for BELVIQ (lorcaserin hydrochloride); (ii) $23.4 million received subsequent to June 30 from the exercise of warrants and stock options; or (iii) $65.0 million for milestone payments that Arena is eligible to receive from Eisai following US Drug Enforcement Administration (DEA) scheduling designation and delivery of BELVIQ launch supply to Eisai.

"The FDA's approval of BELVIQ in the second quarter was a significant development for obese and overweight Americans who need help losing weight," said Jack Lief, Arena's President and Chief Executive Officer. "We are focused on working with Eisai to launch BELVIQ in the United States following the completion of DEA scheduling, and expect BELVIQ to play a key role in physicians' newly expanded toolkits for the medical management of obesity. We also have marketing authorization applications under review in the European Union and Switzerland, and are in the process of prioritizing our commercial and regulatory strategy for additional markets outside of the United States."

Recent BELVIQ (lorcaserin HCl) Developments

  • Obtained FDA approval of BELVIQ as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management i
    '/>"/>

  • SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Arena Pharmaceuticals Announces First Quarter 2012 Financial Results and Recent Developments
    2. Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
    3. Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
    4. Aperture Health, Inc., Targeting the Strong Growth in the Long Term Disease Management arena
    5. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
    6. Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference
    7. Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control
    8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9
    9. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
    10. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
    11. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/6/2015)... , March 6, 2015 Ultra ... from Intuitive Surgical, the manufacturer of da ... Instrument Cleaning System. This approval reflects the unit,s ... cleanliness currently in place for the sterile processing ... for reprocessing robotic surgical instruments for re-use. ...
    (Date:3/6/2015)... 6, 2015  Aethlon Medical, Inc. (OTCQB:AEMD), the pioneer ... and cancer, today announced that James A. Joyce ... a corporate overview at the 27th Annual ROTH Conference ... Aethlon was previously scheduled to present at 5:30 pm ... be held at The Ritz-Carlton Hotel in ...
    (Date:3/6/2015)... UNION CITY, Calif. , March 6, 2015 /PRNewswire/ ... products company manufacturing point-of-care instruments and consumables for the ... lab services to the veterinary and research markets in ... that the Center for Veterinary Biologicals of the U.S. ... Rapid Test Kit for the detection of   A. ...
    Breaking Medicine Technology:Ultra Clean Systems Reaches Exclusive Place within Robotic Surgical Instrument Cleaning Industry with Latest Certifications 2Update - Changed Time for Aethlon Medical Presentation at the 27th Annual ROTH Conference 2Abaxis, Inc. Announces USDA Clearance of VetScan Anaplasma Rapid Test 2Abaxis, Inc. Announces USDA Clearance of VetScan Anaplasma Rapid Test 3
    ... September 28, 2011 ReportsnReports - U.S. ... Rehabilitation Technology Market This ... the U.S. Rehabilitation Technologies Market: clinical electrotherapy - ... - laser therapy, clinical electrotherapy - diathermy, continuous ...
    ... Inc., the worldwide leader in handheld x-ray technologies, has ... Directors has appointed Ken Kaufman as President and Chief ... retain his title as Chairman and CEO, and assume ... absolutely excited to join Aribex full-time," said Kaufman. "We ...
    Cached Medicine Technology:ReportsnReports Adds Market Research Report on U.S. Rehabilitation Technology Market in its Store 2ReportsnReports Adds Market Research Report on U.S. Rehabilitation Technology Market in its Store 3ReportsnReports Adds Market Research Report on U.S. Rehabilitation Technology Market in its Store 4ReportsnReports Adds Market Research Report on U.S. Rehabilitation Technology Market in its Store 5Aribex Announces Leadership Reorganization 2
    (Date:3/6/2015)... US Sports Football Camps expands its network ... non-contact specialty camps and one contact football camp. The ... located at Bowie State University and Riverdale Baptist School. ... speed and strength of football athletes. The contact football ... Graves, former quarterback in the Canadian Football League, as ...
    (Date:3/6/2015)... Further solidifying their position as a ... announced today that the company has earned Inavero’s Best ... of Staffing Talent Award five years in a row. ... Talent Diamond winners are proven industry leaders in service ... the individuals they have helped find temporary and permanent ...
    (Date:3/6/2015)... (PRWEB) March 06, 2015 At ... company, announced today the launch of its powerful, ... on healthy and sustainable products at any retailer ... is exhibiting at Expo West Booth 6054. ... by gluten-free, Kosher, non-GMO, organic, Paleo, and vegan, ...
    (Date:3/6/2015)... Williamsport, PA (PRWEB) March 06, 2015 ... warning of a national shortfall of 90,000 doctors by ... media, Susquehanna Health (SH) is proactively preparing ... development, recruitment and patient access. , Several factors ... population, increasing number of insured under the Affordable Care ...
    (Date:3/6/2015)... Johnson & Johnson and Ethicon were hit with ... in Superior Court in the State of California in ... 12 awarded Mrs. Perry $700,000 in actual damages for ... TVT Abbrevo plastic sling for stress urinary incontinence. The ... $5 million in punitive damages. , According to court ...
    Breaking Medicine News(10 mins):Health News:US Sports Camps to Host Three New Football Camps in Maryland 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 3Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 3Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 3Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 4Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3
    ... Thursday 17 June 2010: Smoking cigarettes is a significant ... have a negative impact on the effectiveness of anti-tumour ... treatments, according to results of two studies presented today ... League Against Rheumatism in Rome, Italy. A further study ...
    ... ... will be an exciting event for Tosoh Bioscience (Booth #7714) as the company plans to unveil ... HPLC testing. , ... -- The AACC 2010 Annual Meeting in Anaheim, CA will be an exciting event ...
    ... ... Focus on Shared Goals of EHR and Practice Management Innovation , ... Carrollton, GA (PRWEB) June 17, 2010 ... practice management and interoperability solution PrimeSuite®, has been named as a corporate partner of ...
    ... costlier drugs increased after new rules took effect, study ... in Medicare payments to doctors who administer outpatient chemotherapy ... among Medicare recipients, finds a new study. , "This ... would expect, but economists often encounter this sort of ...
    ... ... innovative, technology-enhanced, nutrition company, announced today that it is expanding their medical advisory team. ... join this highly-respected team of doctors and scientists. , ... (PRWEB) June 17, 2010 -- Dr. Droste ...
    ... ... a rapidly growing online medical supplies superstore, announces a new partnership with ... lightweight wheelchairs to diabetic test supplies—can be purchased easily and securely by ... ...
    Cached Medicine News:Health News:Smoking cigarettes is a predictor of RA and may negatively impact on efficacy of anti-TNFs 2Health News:Smoking cigarettes is a predictor of RA and may negatively impact on efficacy of anti-TNFs 3Health News:AACC 2010 Creates Excitement for Tosoh Immunoassay and HPLC Analyzers 2Health News:Greenway Partners with National Healthcare Consultancy 2Health News:Greenway Partners with National Healthcare Consultancy 3Health News:Medicare Cuts May Have Led Docs to Prescribe More Chemo 2Health News:Discount Medical Supplies Provider Now Offering International Checkout 2
    ... CryoCath has developed a minimally invasive ... tachycardia. It delivers a very high ... confirmation, pinpoint site precision, minimal tissue ... and stenosis., ,Freezor Xtra allows physicians ...
    ... is a malleable, single-use cryosurgical probe developed ... The probe will ablate cardiac tissue while ... surgical procedure, such as coronary artery bypass ... and/or repair and as part of the ...
    ... CryoCath has developed a minimally invasive ... tachycardia. It delivers a very high ... confirmation, pinpoint site precision, minimal tissue ... and stenosis., ,Freezor is a flexible, ...
    The Medtronic CardioRhythm Marinr Catheter is intended for use in diagnostic electrophysiologic procedures. These catheters are designed for recording intracardiac electrograms and temporary pacing a...
    Medicine Products: